Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
about
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementProgress of artificial pancreas devices towards clinical use: the first outpatient studiesContinuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesIdentification of Main Factors Explaining Glucose Dynamics During and Immediately After Moderate Exercise in Patients With Type 1 Diabetes.Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.Assessing sensor accuracy for non-adjunct use of continuous glucose monitoringSafety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreasA randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover studyAutomated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies.Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.Continuous glucose monitoring in 2014.Psychosocial assessment of artificial pancreas (AP): commentary and review of existing measures and their applicability in AP researchUnsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4)Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?Continuous glucose monitoring in 2013.Closed-loop artificial pancreas systems: engineering the algorithms.Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.Physical activity and type 1 diabetes: time for a rewire?Multivariable Adaptive Artificial Pancreas System in Type 1 Diabetes.In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes.Type 1 Diabetes in the Young: Organization of Two National Centers in Israel and Slovenia.Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes.12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial.Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.Type 1 Diabetes in the Young: Organization of Two National Centers in Israel and Slovenia.Artificial Intelligence for Diabetes Management and Decision Support: Literature Review.
P2860
Q26769878-403F83EB-29A5-4EC4-ACEC-35400275BF04Q26825236-AA22C43F-C792-4998-9B35-D329A0B8FCF1Q28071439-F023F3A9-ABBD-44BD-A8F2-313FA95A1FB5Q30274891-BC12D0B6-A803-4041-B97E-685A049DDCE0Q30278498-F7D23F12-7415-425F-BF92-8E32DAB8CCC1Q30278964-D062BF9B-9EF3-4011-8BC1-70D1AA9F1E2CQ30300933-81BF164D-7A38-439C-B654-023997F92BF8Q30301250-C57350B7-2681-44AB-98FA-71386EA6AE4BQ30384396-2006E4B5-F206-4E60-8C89-1E9B7D6FBA86Q33793799-59DE2376-E3A3-418C-A0F5-1628545FCF36Q34194737-8DA91E5B-2D94-4298-A0AC-0F32985E054AQ34243374-473F78DE-BB11-451A-9A5F-1D26E5B6A43CQ34360613-6A0EBEEF-39C4-4F7A-933C-76EDD7FFC825Q35097775-C067EC44-8B20-4C8A-A702-E99E9CBF59F6Q35193787-6B518C7A-1C1A-4F18-9ACD-E7D8E2530D06Q35877744-20ED0F5B-F399-4B9C-9371-AA43E2ED72A8Q36259845-271C32C9-AF32-4550-B562-46A7ABED61E4Q37275651-BA4285A9-F140-452F-B402-0C4CCF4FAFC4Q37288511-97CAA6D3-A0A8-4CDF-A8C6-933DAC224962Q37577292-15E4E850-B2D5-446E-A39D-D6F22EC1671FQ37715545-5C5F3B46-E6A7-48BA-BC53-6636569879B0Q37715553-C7893C61-1446-45F3-B758-FFB3A86B0658Q38205861-1DB14997-0920-4C45-976A-B66676A2CE21Q38310888-3CB64397-2FC2-4695-AD48-BE68144A3ACDQ38622678-943E3B0A-6723-4F90-9153-A29474E3091CQ38874532-2BC94A6C-D27B-4881-BAE5-8A92E21D385BQ38959162-6F5E4BD7-2780-4788-9CF9-4B8C1B040EDCQ39051106-5F4DEF8A-7212-4D51-9C78-CEB1594C6D1CQ42408972-FA14D0CE-14D9-4E80-8323-F6F7EC83184BQ42696179-D843CD54-0F70-44D1-B098-F9A7809F74F6Q42718199-000035A1-61B7-4EC1-B4CB-07FDDAB59268Q44372769-341F2E6D-5074-426A-8DDC-1353217D6E46Q44722129-D40425B7-25B4-4386-BAA7-5B17116C8F43Q47288459-2993C7EC-C7C4-487E-A9AD-1015C14A5E90Q47778034-B2B9C4C8-1C26-4016-9FB3-6A8BCC9B0C68Q51008011-F05A1E28-524E-486A-B6B2-B8FD9C9F7974Q55009441-6B8BFD7A-9ED0-4BCA-8F31-E7105D8C68DCQ55208803-891010DC-53D2-44DB-88F2-481FEB4F0DDE
P2860
Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Night glucose control with MD- ...... ssover trial-interim analysis.
@en
type
label
Night glucose control with MD- ...... ssover trial-interim analysis.
@en
prefLabel
Night glucose control with MD- ...... ssover trial-interim analysis.
@en
P2093
P2860
P356
P1433
P1476
Night glucose control with MD- ...... ssover trial-interim analysis.
@en
P2093
Christiana Tsioli
Eran Atlas
Ido Muller
Moshe Phillip
Natasa Bratina
Olga Kordonouri
Revital Nimri
Shahar Miller
Thomas Danne
P2860
P356
10.1111/PEDI.12071
P577
2013-08-15T00:00:00Z